Georgia vs Marshall Islands: HIV-positive TB patients on ART (antiretroviral therapy)
Georgia
100.0%
in 2024
Marshall Islands
100.0%
in 2019
Georgia rank
1st
Marshall Islands rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Georgia
- Marshall Islands
How they compare
Georgia currently reports 100.0% against 100.0% in Marshall Islands, a difference of 0.0%.
Across all 5 years both countries report, Marshall Islands has been ahead every year.
Georgia ranks 1st and Marshall Islands ranks 1st of 144 countries.
Marshall Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Georgia | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 55.0% | 100.0% | 45.0% | Marshall Islands |
| 2010s | 87.8% | 100.0% | 12.2% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Georgia or Marshall Islands?
- Georgia, at 100.0% against 100.0% in Marshall Islands as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Georgia and Marshall Islands?
- 0.0%, with Georgia ahead.
- How many years of comparable data are there for Georgia and Marshall Islands?
- 5 years are reported by both, from 2009 to 2019.
- How do Georgia and Marshall Islands rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Georgia ranks 1st and Marshall Islands ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.